Constrained dipeptide mimetic templates were designed to mimic the secondar
y structure of peptides in a beta-strand conformation. Two templates corres
ponding to the D-Phe-Pro portion of the thrombin inhibitor D-Phe-Pro-ArgCH(
2)Cl were synthesized and converted into nine alpha-ketoamide and alpha-ket
oheterocycle inhibitors of thrombin. Additionally, a template corresponding
to L-Phe-Pro was synthesized and converted to a thrombin inhibitor. The in
vitro inhibition of thrombin by these compounds was determined, and those
corresponding to the D-Phe-Pro were found to be more potent inhibitors than
the L-Phe-Pro mimetic. The alpha-ketoamides were found to be more potent t
han the alpha-ketoheterocycles but had much slower on rates. By comparison
of a series of alpha-ketoamide analogues, it is apparent that the there is
a preference for binding of bulky hydrophobic substituents in the P' portio
n of the thrombin active site. Three of the inhibitors (MOL098, MOL144, and
MOL174) were screened against a series of coagulation and anticoagulation
enzymes and found to be selective for inhibition of the coagulation enzymes
. Two of the inhibitors were tested in in vitro models of intestinal absorp
tion and found to have low absorption potential. The compounds were then te
sted in vivo in both rats and primates, and one of them (MOL144) was approx
imately 25% absorbed in both species. This study has delineated the synthes
is of constrained dipeptide beta-strand mimetics and validated the potentia
l for compounds of this type as potent thrombin inhibitors and possible dru
g leads.